microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2 - PubMed (original) (raw)

microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2

Jing Nie et al. Carcinogenesis. 2012 Jan.

Abstract

Deregulated microRNAs participate in carcinogenesis and cancer progression, but their roles in cancer development remain unclear. In this study, miR-365 expression was found to be downregulated in human colon cancer tissues as compared with that in matched non-neoplastic mucosa tissues, and its downregulation was correlated with cancer progression and poor survival in colon cancer patients. Functional studies revealed that restoration of miR-365 expression inhibited cell cycle progression, promoted 5-fluorouracil-induced apoptosis and repressed tumorigenicity in colon cancer cell lines. Furthermore, bioinformatic prediction and experimental validation were used to identify miR-365 target genes and indicated that the antitumor effects of miR-365 were probably mediated by its targeting and repression of Cyclin D1 and Bcl-2 expression, thus inhibiting cell cycle progression and promoting apoptosis. These results suggest that downregulation of miR-365 in colon cancer may have potential applications in prognosis prediction and gene therapy in colon cancer patients.

PubMed Disclaimer

Similar articles

• MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7.
  Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H, Wang W, Zhang L, Zhang X, Tang Q, Zhang C, Tao J, Wang X, Gao X. Li Q, et al. Cancer Lett. 2013 Jul 10;335(1):168-74. doi: 10.1016/j.canlet.2013.02.029. Epub 2013 Feb 19. Cancer Lett. 2013. PMID: 23435373
• MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
  Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, Wang Z, Wang Z, Cheng P, Tong D, Li C, Tang H. Ji F, et al. Bone. 2013 Sep;56(1):220-6. doi: 10.1016/j.bone.2013.05.020. Epub 2013 Jun 10. Bone. 2013. PMID: 23756231
• microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.
  Liu L, Chen L, Xu Y, Li R, Du X. Liu L, et al. Biochem Biophys Res Commun. 2010 Sep 17;400(2):236-40. doi: 10.1016/j.bbrc.2010.08.046. Epub 2010 Aug 19. Biochem Biophys Res Commun. 2010. PMID: 20727858
• Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis.
  He JF, Luo YM, Wan XH, Jiang D. He JF, et al. J Biochem Mol Toxicol. 2011 Nov-Dec;25(6):404-8. doi: 10.1002/jbt.20396. J Biochem Mol Toxicol. 2011. PMID: 22190509 Review.
• Alterations of microRNAs contribute to colon carcinogenesis.
  Schetter AJ, Harris CC. Schetter AJ, et al. Semin Oncol. 2011 Dec;38(6):734-42. doi: 10.1053/j.seminoncol.2011.08.009. Semin Oncol. 2011. PMID: 22082759 Free PMC article. Review.

Cited by

• IGF-I 3' untranslated region: strain-specific polymorphisms and motifs regulating IGF-I in osteoblasts.
  Smith SS, Kessler CB, Shenoy V, Rosen CJ, Delany AM. Smith SS, et al. Endocrinology. 2013 Jan;154(1):253-62. doi: 10.1210/en.2012-1476. Epub 2012 Nov 26. Endocrinology. 2013. PMID: 23183171 Free PMC article.
• Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.
  Guo W, Liu R, Ono Y, Ma AH, Martinez A, Sanchez E, Wang Y, Huang W, Mazloom A, Li J, Ning J, Maverakis E, Lam KS, Kung HJ. Guo W, et al. Mol Pharmacol. 2012 Nov;82(5):938-47. doi: 10.1124/mol.112.079889. Epub 2012 Aug 16. Mol Pharmacol. 2012. PMID: 22899868 Free PMC article.
• Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.
  Liu H, Du L, Wen Z, Yang Y, Li J, Wang L, Zhang X, Liu Y, Dong Z, Li W, Zheng G, Wang C. Liu H, et al. Int J Colorectal Dis. 2013 May;28(5):697-703. doi: 10.1007/s00384-013-1674-0. Epub 2013 Mar 10. Int J Colorectal Dis. 2013. PMID: 23474644
• microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2.
  Long LM, He BF, Huang GQ, Guo YH, Liu YS, Huo JR. Long LM, et al. Oncol Lett. 2015 Feb;9(2):645-650. doi: 10.3892/ol.2014.2746. Epub 2014 Nov 28. Oncol Lett. 2015. PMID: 25621032 Free PMC article.
• MicroRNA-365 targets multiple oncogenes to inhibit proliferation, invasion, and self-renewal of aggressive endometrial cancer cells.
  Wang C, Su K, Zhang Y, Zhang W, Chu D, Zhao Q, Guo R. Wang C, et al. Cancer Manag Res. 2018 Oct 30;10:5171-5185. doi: 10.2147/CMAR.S174889. eCollection 2018. Cancer Manag Res. 2018. PMID: 30464615 Free PMC article. Retracted.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program